Estabrook Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.7K | Hold |
69
| – | – | ﹤0.01% | 213 |
|
|
2025
Q1 | $33.5K | Hold |
69
| – | – | 0.01% | 203 |
|
|
2024
Q4 | $27.8K | Hold |
69
| – | – | ﹤0.01% | 221 |
|
|
2024
Q3 | $32.1K | Hold |
69
| – | – | ﹤0.01% | 219 |
|
|
2024
Q2 | $32.3K | Hold |
69
| – | – | 0.01% | 219 |
|
|
2024
Q1 | $28.8K | Hold |
69
| – | – | ﹤0.01% | 233 |
|
|
2023
Q4 | $28.1K | Hold |
69
| – | – | ﹤0.01% | 231 |
|
|
2023
Q3 | $24K | Hold |
69
| – | – | ﹤0.01% | 242 |
|
|
2023
Q2 | $24.3K | Hold |
69
| – | – | ﹤0.01% | 247 |
|
|
2023
Q1 | $21.7K | Hold |
69
| – | – | ﹤0.01% | 262 |
|
|
2022
Q4 | $19.9K | Hold |
69
| – | – | ﹤0.01% | 269 |
|
|
2022
Q3 | $20K | Hold |
69
| – | – | ﹤0.01% | 263 |
|
|
2022
Q2 | $19.4K | Hold |
69
| – | – | ﹤0.01% | 281 |
|
|
2022
Q1 | $18K | Hold |
69
| – | – | ﹤0.01% | 290 |
|
|
2021
Q4 | $15.2K | Buy |
+69
| New | +$15.2K | ﹤0.01% | 309 |
|
|
2015
Q3 | – | Sell |
-90
| Closed | -$11.1K | – | 471 |
|
|
2015
Q2 | $11.1K | Hold |
90
| – | – | ﹤0.01% | 345 |
|
|
2015
Q1 | $10.6K | Hold |
90
| – | – | ﹤0.01% | 367 |
|
|
2014
Q4 | $10.7K | Hold |
90
| – | – | ﹤0.01% | 373 |
|
|
2014
Q3 | $10.1K | Hold |
90
| – | – | ﹤0.01% | 383 |
|
|
2014
Q2 | $8.52K | Buy |
+90
| New | +$8.52K | ﹤0.01% | 397 |
|